The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index; 11 of the 47 sources its claims cite were checked for support.
Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism
Open accessAbstract
Despite the crucial role of the liver in glucose homeostasis, a detailed mathematical model of human hepatic glucose metabolism is lacking so far. Here we present a detailed kinetic model of glycolysis, gluconeogenesis and glycogen metabolism in human hepatocytes integrated with the hormonal control of these pathways by insulin, glucagon and epinephrine. Model simulations are in good agreement with experimental data on (i) the quantitative contributions of glycolysis, gluconeogenesis, and glycogen metabolism to hepatic glucose production and hepatic glucose utilization under varying physiological states. (ii) the time courses of postprandial glycogen storage as well as glycogen depletion in overnight fasting and short term fasting (iii) the switch from net hepatic glucose production under hypoglycemia to net hepatic glucose utilization under hyperglycemia essential for glucose homeostasis (iv) hormone perturbations of hepatic glucose metabolism. Response analysis reveals an extra high capacity of the liver to counteract changes of plasma glucose level below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia). Our model may serve as an important module of a whole-body model of human glucose metabolism and as a valuable tool for understanding the role of the liver in glucose homeostasis under normal conditions and in diseases like diabetes or glycogen storage diseases.
Overview
CoChat Summary
TL;DR
The paper presents a detailed kinetic model of human hepatic glucose metabolism integrating insulin, glucagon, and epinephrine control via enzyme phosphorylation state. Model simulations reproduce experimental data on hepatic glucose production/utilization, glycogen storage and depletion, fasting, and hormone perturbations, and reveal high hepatic counter-regulatory capacity below 5 mM and above 7.5 mM glucose.
Key findings
- The liver switches between net hepatic glucose production (HGP) and net hepatic glucose utilization (HGU) at a set point of 6.6 mM glucose for half-filled glycogen stores, varying from 5.4 mM for empty to 7.5 mM for filled stores; the gluconeogenesis/glycolysis set point is 8.5 mM for half-filled glycogen, and the glycogenesis/glycogenolysis set point is 5.1 mM.
- In short-term fasting, HGP decreases to a constant basal rate of 7–8 µmol/kg(bw)/min around 40 h; after an overnight fast about half of HGP comes from glycogenolysis, whereas after 40 h fasting only 10% comes from glycogen and 90% from gluconeogenesis. The model predicts ∼8.5 µmol/kg(bw)/min HGP for 20 h at 3 mM glucose with 95% from gluconeogenesis, compared with experimental values of 7.56–9.8 µmol/kg(bw)/min HGP and 92–97% gluconeogenesis.
- Hormone perturbation simulations show that insulin and glucagon depletion or glucagon depletion alone reduce HGP to around 70% of basal values, while insulin depletion increases HGP to around 130%; basal glucagon is responsible for about 30% of HGP.
- The hepatic glucose response coefficient indicates an extra high capacity to counteract plasma glucose changes below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia), with high-response regions below 4 mM and above 8 mM glucose.
Methods
- The model consists of 49 localized metabolites and 36 reactions compartmentalized into cytosol, mitochondrion, and blood, with individual kinetics for reactions and transporters; it includes allosteric regulation and hormonal regulation via phosphorylation/dephosphorylation of interconvertible enzymes (GS, GP, PFK2, FBP2, PK, and PDH).
- Experimental flux data were human-specific, metabolite concentrations were taken from human and rat liver, HGP/gluconeogenesis/glycogenolysis data came from 25 independent studies, and hormone glucose-response curves were fitted to oral glucose tolerance tests and hypoglycemic, hyperinsulinemic clamp studies.
- The differential equation system was integrated with MATLAB ode15s; steady-state and quasi-steady-state simulations varied blood glucose from 2 to 14 mM and glycogen from 0 to 500 mM, with metabolic control analysis and hepatic glucose response coefficient calculations.
Limitations
- The paper states that hormone signal transduction is phenomenological due to lack of quantitative signaling data; cellular redox and energy states are held constant; the model represents an “average” hepatocyte and neglects metabolic zonation; gene expression changes are not included; and the phosphorylation state of all regulatory enzymes is assumed equal and instantaneous.
- The paper also notes that the model comprises fairly active futile cycles in glycogen metabolism, the PFK1/FBPase1 system, and between PEPCK and PK, and that it is not able to simulate conditions where energy decoupling is invalid, such as hypoxic or ischemic conditions.
- Evident from the text: external blood glucose and lactate concentrations were kept fixed in all simulations, and gluconeogenic substrates other than lactate were neglected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glycogen metabolism and hormone perturbations. (A) Decrease in glycogen during short term fasting over 60 h. Experimental data from [22] (individual data) and [23] (mean data with STD) given in Dataset S1. Simulation time courses (dashed lines) start from filled glycogen stores (500 mM). Blood glucose is varied between 3.6 mM (red) and 5.0 mM (green) in steps of 0.2 mM (black). The blue curve corresponds to a situation where the plasma glucose concentration changes from initially 5 mM to 3.6 mM in 60 h. Higher blood glucose results in a slower decrease in glycogen. (B) Increase in glycogen after a glucose load. Experimental data from [8], [24], [25] given in Dataset S1. Simulation time courses (dashed lines) start from initial glycogen concentration of 200 mM. Blood glucose concentrations are varied between 5.5 mM (red) and 8.0 mM (green) in steps of 0.5 mM (black). The blue line corresponds to 7 mM. Higher blood glucose results in a faster increase in glycogen after a glucose load. (C) Change in HGP and plasma glucose in insulin deficiency. Insulin (blue) and glucagon (red) time courses for an idealized hormone perturbation (left), the experimental data from [27] (middle), and a simulation taking the experimental profile of hormones and glucose utilization into account are shown in the top row. Middle row depicts the time courses of HGP (red) and whole-body glucose utilization GU (black). Bottom row shows the resulting change in plasma glucose as a consequence of the changes in HGP. Insulin deficiency increases HGP relative to GU resulting in an increase in plasma glucose. After insulin normalization HGP decreases and falls below GU due to the increased blood glucose. (D) Changes in HGP during the infusion period (135–200 min) relative to the pre-infusion period (85–135 min) for the simulations and experiments and the various hormone perturbations. Saline infusion (Figure S1) and somatostatin infusion with insulin and glucagon restauration (Figure S5) have no effect on basal HGP. Insulin and glucagon deficiency (Figure S2) and glucagon deficiency alone (Figure S3) decrease HGP relative to basal values. Insulin deficiency increases basal HGP (Figure 4C, Figure S4).](https://figures.cochat.ai/paper-figures/87490a05018a4b85974b7ba672eac06d/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-4.jpg)
![Figure 5 HGP/HGU and HGRC. Steady state solution of time course simulations under constant glycogen and blood glucose concentration (every data points correspond to a single simulation to steady state). Glycogen is varied between 0 and 500 mM in steps of 5 mM, blood glucose is varied between 2 and 14 mM in steps of 0.05 mM. (A) HGP (red)/HGU (green) ([]) corresponding to GLUT2 flux. The liver switches between HGP and HGU depending on the blood glucose and glycogen. The set point varies between 5.4 mM for empty and 7.5 mM for completely filled glycogen stores (6.6 mM at glycogen 250 mM). (B) HGRC ([]). Response of the liver to changes in the blood glucose. Two main regions of high response exist: A hypoglycemic region below 4 mM, and a hyperglycemic region above 8 mM glucose. (C) gluconeogenesis (red)/glycolysis (green) ([]) corresponding to glucose-6p isomerase (GPI) flux. The gluconeogenesis/glycolysis set point varies between 8.8 mM for empty and 7.0 mM for filled glycogen stores. (D) glycogenolysis (red)/glycogenesis (green) ([]) corresponding to flux through glucose-1p isomerase (G1PI).](https://figures.cochat.ai/paper-figures/4d457956c15a4280b6d22553178050f2/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-5.jpg)
Verification
Claims the paper makes
10 Valid · 0 Not valid · 19 Not checked · 112 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] DL Rothman, 1991, Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR., Science source
- Partly supportedcites [23] I Magnusson, 1992, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., J Clin Invest sourceExperimental — accuracy not yet measured
The citation is attached to the description of 3–5 mM as the normal fasting-glucose range, not to the citing authors’ conclusion about their simulations. Table I in the Results reports fasting plasma glucose of 5.4 ± 0.2 and 5.1 ± 0.2 mmol/L in healthy controls after 16 and 23 hours, respectively, but does not establish 3 mM as a normal lower bound. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To further evaluate the predictive capacity of our model, we performed time-course simulations of experimentally determined glycogen levels in dogs monitored under conditions of hyperglycemic, hyperinsulinemic clamps and administration of a mixed meal diet [26], as can be seen from the respective figures in the supplement (Figure S1, S2, S3, S4, S5, S6), our model simulation were in good agreement”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogen synthesis postprandial
What the sources say
- Partly supportedcites [26] M Krssak, 2004, Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes., Diabetes sourceExperimental — accuracy not yet measured
The Research Design and Methods section describes human participants, not dogs, in both the mixed-meal and clamp protocols. Figure 3 reports measured hepatic glycogen time courses for those participants under both conditions. The cited paper therefore supports the use of experimental glycogen time courses, but not their attribution to dogs; the citing authors' model agreement is their own conclusion. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“For all hormone perturbations the time courses of HGP as well as glucose are in good agreement with the experimentally observed changes.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Role of insulin and glucagon for HGP
What the sources say
- Supportedcites [27] AD Cherrington, 1976, The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog., J Clin Invest source
The Methods describe the hormone perturbations, and the Figure 1–2 captions in the Regulation of Glucose Production by Insulin and Glucagon section identify measured time courses of glucose production and plasma glucose concentration in dogs. The cited paper supplies the experimental observations; the judgment that another set of time courses agrees with them is the citing authors’ own comparison. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for glycogen depletion under hypoglycemia (Figure 4A) for glucose concentrations between 3.6 mM (red) and 5 mM (green) are in agreement with experimental data [22], [23].”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] DL Rothman, 1991, Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR., Science source
- Partly supportedcites [23] I Magnusson, 1992, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., J Clin Invest sourceExperimental — accuracy not yet measured
The Results (page not supplied) report a significant decline in liver glycogen during fasting in both diabetic and control subjects. They do not report hypoglycemia at 3.6–5 mM or compare those conditions with the citing paper’s simulations; the reported mean fasting glucose concentrations were 5.1–5.4 mM in controls and higher in diabetic subjects. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Changes in gene expression play a role in adapting hepatic metabolism on longer time scales to for example reduce futile cycles in counteracting pathways (like down-regulation of glucokinase and up-regulation of glucose-6 phosphatase under hypoglycemia) or match glucose metabolism to physiological requirements (up-regulating of glucose-6 phosphatase under hypoglycemic conditions to increase glucon”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Discussion
What the sources say
- Supportedcites [31] C Vollmers, 2009, Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression., Proc Natl Acad Sci U S A source
The Discussion (“Food Modulated Transcripts Constitute a Metabolic Sand Timer”; page unavailable) reports that hepatic transcripts change with feeding and fasting, with fasting-induced transcripts accumulating as fasting continues. The Results (“Daily Rhythms in Metabolic Regulators”; page unavailable) link these changes to regulators of cellular energy metabolism, supporting the broad claim about gene expression and longer-term metabolic adaptation. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
74 more claims · 3 with their cited sources checked
Create a free account to see all 141 claims and every source verdict.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 14
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [56] | 10 | 12.2 | 7.4 | 3.8 | 60 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 12.2 · recomputed 11.2
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [67] | 16 | 17.5 | 8.9 | 8.2 | 51 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 17.5 · recomputed 17.1
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glucose (a) | [58] | 18 | 8.5 | 5.9 | 2.6 | 59 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 59 · recomputed 69.411765
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glycerol MIDA | [49] | 60 | 7.87 | 7.71 | 1.58 | 98 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 7.87 · recomputed 9.29
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results
“Blood glucose is varied between 3.6 mM (red) and 4.6 mM (green) in steps of 0.2 mM.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865
Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression.
Vollmers, C., Gill, S., DiTacchio, L., Pulivarthy, S. R., Le, H. D., & Panda, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909591106 · Cited by 765 · cited 1×
“is strongly dependent on the external concentration of glucose and to a much lesser extent on the glycogen level. (ii) Under hypoglycemic conditions main control of hepatic glucose metabolism is exerted by a completely different set of reactions than in hyperglycemia. (iii) The response of the opposing pathway couples…”
BackgroundMagnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595
Zonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589 · cited 1×
“A model is always an abstraction of reality describing a certain subset of biological phenomena. The underlining assumptions are crucial for to understand the range of application of the model and the limitations. Main model assumptions and simplifications are (i) usage of phenomenological functions to incorporate hor…”
BackgroundMitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Quantitation of Hepatic Glycogenolysis And Gluconeogenesis in Fasting Humans With 13 C NMR
Rothman, D. L., Magnusson, I., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1991) · Science · doi:10.1126/science.1948033 · Cited by 546
Ovbiagele, B. I., Kidwell, C. S., & Saver, J. L. (2005) · Cited by 454
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109464 · Cited by 421
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Rizza, R. A. (2010) · Diabetes · doi:10.2337/db10-1032 · Cited by 367
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes.
Krssak, M., Brehm, A., Bernroider, E., Anderwald, C., Nowotny, P., Man, C. D., Cobelli, C., Cline, G. W., Shulman, G. I., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3048 · Cited by 313 · cited 1×
“(mean person data) for the glycogen synthesis. The only difference between model simulations in states of either net glycogen synthesis or net glycogenolysis simulations are differences in the initial glycogen and blood glucose concentrations. Experimental data for the mixed meal and hyperglycemic, hyperinsulinemic cl…”
BackgroundThe disposal of an oral glucose load in patients with non-insulin-dependent diabetes
Ferrannini, E., Simonson, D. C., Katz, L. D., Reichard, G., Bevilacqua, S., Barrett, E. J., Olsson, M., & DeFronzo, R. A. (1988) · Metabolism · doi:10.1016/0026-0495(88)90033-9 · Cited by 305
Decreased Epinephrine Responses to Hypoglycemia during Sleep
Jones, T. W., Porter, P., Sherwin, R. S., Davis, E. A., O'Leary, P., Frazer, F., Byrne, G., Stick, S., & Tamborlane, W. V. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382303 · Cited by 301
The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
Chen, X., Iqbal, N., & Boden, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5479 · Cited by 291
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis.
Radziuk, J., & Pye, S. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.217 · Cited by 267
Taylor, R., Magnusson, I., Rothman, D. L., Cline, G. W., Caumo, A., Cobelli, C., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118379 · Cited by 258
Degn, K. B., Brock, B., Juhl, C. B., Djurhuus, C. B., Grubert, J., Kim, D., Han, J., Taylor, K., Fineman, M., & Schmitz, O. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2397 · Cited by 254
Cherrington, A. D., Chiasson, J. L., Liljenquist, J. E., Jennings, A. S., Keller, U., & Lacy, W. W. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108596 · Cited by 249
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis
Boden, G., Cheung, P., Stein, T. P., Kresge, K., & Mozzoli, M. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00429.2001 · Cited by 248
Chemical modification of proteins by methylglyoxal.
Degenhardt, T. P., Thorpe, S. R., & Baynes, J. (1998) · PubMed · Cited by 243
Gerich, J. E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80207-1 · Cited by 224 · cited 1×
“The human plasma glucose is kept in a narrow range between minimum values of ∼3 mM after prolonged fasting or extensive muscle activity and maximum values of ∼9 mM reached postprandially”
BackgroundGlucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198
Knop, F. K., Vilsbøll, T., Madsbad, S., Holst, J. J., & Krarup, T. (2007) · Diabetologia · doi:10.1007/s00125-006-0566-z · Cited by 193
Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.
Hellerstein, M. K., Neese, R. A., Linfoot, P., Christiansen, M., Turner, S., & Letscher, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119644 · Cited by 188
Skyler, J. S. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70323-6 · Cited by 186
Splanchnic regulation of glucose production
Wahren, J., & Ekberg, K. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093806 · Cited by 185
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., & Cryer, P. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.4.e380 · Cited by 183
Gastaldelli, A., Toschi, E., Pettiti, M., Frascerra, S., Quiñones-Galvan, A., Sironi, A. M., Natali, A., & Ferrannini, E. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1807 · Cited by 168
Consoli, A., Kennedy, F., Miles, J., & Gerich, J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113206 · Cited by 167
Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus
Boden, G., Chen, X., & Stein, T. P. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e23 · Cited by 167
Quantifying gluconeogenesis during fasting
Chandramouli, V., Ekberg, K., Schumann, W. C., Kalhan, S. C., Wahren, J., & Landau, B. R. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1209 · Cited by 154
Nuttall, F. Q., Ngo, A., & Gannon, M. C. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.863 · Cited by 146
Wajngot, A., Chandramouli, V., Schumann, W. C., Ekberg, K., Jones, P. K., Efendic, S., & Landau, B. R. (2001) · Metabolism · doi:10.1053/meta.2001.19422 · Cited by 138
Pathways for glucose disposal after meal ingestion in humans
Woerle, H. J., Meyer, C., Dostou, J. M., Gosmanov, N. R., Islam, N., Popa, E., Wittlin, S. D., Welle, S. L., & Gerich, J. E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00365.2002 · Cited by 133
Chevalier, S., Burgess, S. C., Malloy, C. R., Gougeon, R., Marliss, E. B., & Morais, J. A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1117 · Cited by 132
Butler, P. C., & Rizza, R. A. (1991) · Diabetes · doi:10.2337/diab.40.1.73 · Cited by 130
Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans
Katz, J. J., & Tayek, J. A. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.3.e537 · Cited by 129
Basu, A., Dalla Man, C., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. A. (2009) · Diabetes Care · doi:10.2337/dc08-1826 · Cited by 129
Ackermans, M. T., Arias, A. M. P., Bisschop, P. H. L. T., Endert, E., Sauerwein, H. P., & Romijn, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7383 · Cited by 124
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Woerle, H. J., Szoke, E., Meyer, C., Dostou, J. M., Wittlin, S. D., Gosmanov, N. R., Welle, S. L., & Gerich, J. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00529.2004 · Cited by 120
Bisschop, P. H. L. T., Arias, A. M. P., Ackermans, M. T., Endert, E., Pijl, H., Kuipers, F., Meijer, A. J., Sauerwein, H. P., & Romijn, J. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6573 · Cited by 108
Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting
Boyle, P. J., SHAH, S. D., & Cryer, P. E. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.5.e651 · Cited by 104
Caumo, A., & Cobelli, C. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.5.e829 · Cited by 101
Basu, R., Basu, A., Johnson, C. M., Schwenk, W. F., & Rizza, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2042 · Cited by 97
Effect of Glycemic Control on Glucose Counterregulation During Hypoglycemia in NIDDM
Levy, C. J., Kinsley, B. T., Bajaj, M., & Simonson, D. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1330 · Cited by 81
Henkel, E., Menschikowski, M., Koehler, C., Leonhardt, W., & Hanefeld, M. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.024 · Cited by 81
Glucagon-stimulated phosphorylation of pyruvate kinase in hepatocytes.
Ishibashi, H., & Cottam, G. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34243-6 · Cited by 75
Effects of Basal Insulin Supplementation on Disposition of Mixed Meal in Obese Patients With NIDDM
McMahon, M., Marsh, H. W., & Rizza, R. A. (1989) · Diabetes · doi:10.2337/diab.38.3.291 · Cited by 74
Control Analysis for Autonomously Oscillating Biochemical Networks
Reijenga, K. A., Westerhoff, H. V., Kholodenko, B. Ν., & Snoep, J. L. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75377-0 · Cited by 73 · cited 1×
“values on HGP/HGU, gluconeogenesis/glycolysis and glycogenolysis/gluconeogenesis were analyzed via response coefficients”
MethodSources of carbon in hepatic glycogen synthesis during absorption of an oral glucose load in humans.
Radziuk, J. (1982) · PubMed · Cited by 52
Simulation study of control of hepatic glycogen synthesis by glucose and insulin.
El-Refai, M., & Bergman, R. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.231.5.1608 · Cited by 48
Tounian, P., Schneiter, P., Henry, S., Jéquier, E., & Tappy, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.5.e710 · Cited by 47
A computer model of gluconeogenesis and lipid metabolism in the perfused liver
Chalhoub, E. R., Hanson, R. W., & Belovich, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2007 · Cited by 38
Chalhoub, E. R., Xie, L., Balasubramanian, V., Kim, J., & Belovich, J. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-006-9217-2 · Cited by 35
Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus
Israelian, Z., Szoke, E., Woerle, J., Bokhari, S. M. N. A., Schorr, M., Schwenke, D. C., Cryer, P. E., Gerich, J. E., & Meyer, C. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.013 · Cited by 34
Xu, K., Morgan, K. T., Todd Gehris, A., Elston, T. C., & Gomez, S. M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002272 · Cited by 34
Lerche, S. S., Soendergaard, L., Rungby, J., Møller, N., Holst, J. J., Schmitz, O., & Brock, B. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03510.x · Cited by 32
Ghanaat, F., & Tayek, J. A. (2005) · Metabolism · doi:10.1016/j.metabol.2004.12.003 · Cited by 31
An Integrated Model for the Glucose‐Insulin System
Silber, H. E., Jauslin, P. M., Frey, N., & Karlsson, M. O. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00510.x · Cited by 31
Krudys, K. M., Dodds, M. G., Nissen, S. M., & Vicini, P. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2004 · Cited by 30
Ackermans, M. T. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2220 · Cited by 22
Féry, F., Mélot, C., & BALASSE, E. O. (1993) · Metabolism · doi:10.1016/0026-0495(93)90113-3 · Cited by 21
Stæhr, P., Nielsen, O. H., Beck‐Nielsen, H., Roden, M., Stingl, H., Holst, J. J., Jones, P. K., Chandramouli, V., & Landau, B. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00411.2006 · Cited by 21
Ethnicity affects the postprandial regulation of glycogenolysis
Balasubramanyam, A., McKay, S. V., Nadkarni, P., Rajan, A. S., Garza, A., Pavlik, V., Herd, J. A., Jahoor, F., & Reeds, P. J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e905 · Cited by 20
Thien, H. V., Weverling, G. J., Ackermans, M. T., Hung, N. C., Endert, E., Kager, P. A., & Sauerwein, H. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00026.2004 · Cited by 20
Bisschop, P. H. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1963
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Versatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 407
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
“We first used two independent sets of experimental data from a compendium of steady-state metabolite concentrations of liver cells and steady-state fluxes of DB1 melanoma cells evaluated using a cultured bioreactor (Konig et al., 2012; Shestov et al., 2013).”
MethodGowd, V., Jia, Z., & Chen, W. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.07.015 · Cited by 239
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
Kowalski, G. M., Carey, A. L., Selathurai, A., Kingwell, B. A., & Bruce, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072449 · Cited by 175
“For example, a 10 h fast in humans has relatively minor effects on hepatic glycogen content [49,50], while in mice, a 12 h fast results in almost complete depletion of hepatic glycogen [44].”
Background
Metadata
- Authors
- König, M., Bulik, S., & Holzhütter, H.-G.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- König, Matthias
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-21
- Volume
- 8
- Issue
- 6
- Pages
- e1002577
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC3383054
- OpenAlex
- W2019692827
- Semantic Scholar
- e736ceaff2e762e4127c5127aec4d667b24b6ace
- Cited by
- 202
- References
- 73
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 8 · 2022: 18 · 2021: 14 · 2020: 20 · 2019: 24 · 2018: 22 · 2017: 14 · 2016: 10 · 2015: 10 · 2014: 16 · 2013: 13 · 2012: 4
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- hepatic glucose metabolism, glucose homeostasis, kinetic model, hepatocytes, glycolysis, gluconeogenesis, glycogen metabolism, insulin, glucagon, epinephrine, hepatic glucose production, hepatic glucose utilization, glycogen storage, hypoglycemia, hyperglycemia, diabetes mellitus, glycogen storage disease
- MeSH terms
- Computer Simulation, Fasting, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hypoglycemia, Insulin, Kinetics, Liver, Liver Glycogen, Models, Biological, Computational Biology, Postprandial Period, Glycogenolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.